CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
2.015
+0.015 (0.75%)
Apr 24, 2025, 4:00 PM EDT - Market closed

CASI Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
31449524112366
Upgrade
Market Cap Growth
-54.03%-54.03%291.63%-78.22%-69.41%22.81%
Upgrade
Enterprise Value
3742811776313
Upgrade
Last Close Price
2.022.837.161.798.0029.50
Upgrade
PS Ratio
1.081.542.820.563.7124.15
Upgrade
PB Ratio
16.8723.693.950.361.043.53
Upgrade
P/TBV Ratio
19.3527.184.270.561.555.35
Upgrade
EV/Sales Ratio
1.311.482.400.402.5120.66
Upgrade
Debt / Equity Ratio
11.9611.960.880.020.020.03
Upgrade
Asset Turnover
0.440.440.400.370.230.13
Upgrade
Inventory Turnover
1.651.651.263.947.703.22
Upgrade
Quick Ratio
0.860.862.453.784.438.90
Upgrade
Current Ratio
1.091.093.554.324.709.28
Upgrade
Return on Equity (ROE)
-301.80%-301.80%-57.65%-46.04%-33.89%-48.18%
Upgrade
Return on Assets (ROA)
-38.01%-38.01%-18.43%-14.12%-16.55%-18.08%
Upgrade
Return on Capital (ROIC)
-70.63%-70.63%-27.80%-18.56%-20.30%-20.55%
Upgrade
Earnings Yield
-125.76%-89.54%-28.24%-168.40%-32.77%-13.21%
Upgrade
FCF Yield
-94.33%-67.16%-21.15%-109.63%-32.00%-7.49%
Upgrade
Buyback Yield / Dilution
-14.82%-14.82%2.10%-0.27%-23.23%-15.12%
Upgrade
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q